Palvella Therapeutics, Inc.

The table below shows Palvella Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Palvella Therapeutics, Inc. reported annual revenue of $42.81M for fiscal year 2023. That is up 65.3% from $25.90M in fiscal 2022. Over the 10 fiscal years shown, annual revenue grew from $5.37M (FY 2014) to $42.81M. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.